Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene

Molecular Cell

Volumn 20, Issue 6, 2005, Pages 881-890

  Ghigna, Claudia ^a   Giordano, Silvia ^b   Shen, Haihong ^c   Benvenuto, Federica ^d   Castiglioni, Fabio ^e   Comoglio, Paolo Maria ^b   Green, Michael R ^c   Riva, Silvano ^a   Biamonti, Giuseppe ^a  

^a CNR   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN ASF; PROTEIN RON; PROTEIN SF2; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CANCER; CELL MIGRATION; CELL MOTILITY; COLON CANCER; CONTROLLED STUDY; ENHANCER REGION; EXON; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ONCOGENE; RNA INTERFERENCE;

ALTERNATIVE SPLICING; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; ENHANCER ELEMENTS (GENETICS); EXONS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RECEPTOR PROTEIN-TYROSINE KINASES; RNA INTERFERENCE; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 29144447982     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2005.10.026     Document Type: Article

References (38)

1. C. Bardella, B. Costa, P. Maggiora, S. Patane, M. Olivero, G.N. Ranzani, M. De Bortoli, P.M. Comoglio, and M.F. Di Renzo Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression Cancer Res. 64 2004 5154 5161
2. B.M. Brinkman Splice variants as cancer biomarkers Clin. Biochem. 37 2004 584 594
3. J.F. Caceres, and A.R. Krainer Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains EMBO J. 12 1993 4715 4726
4. L. Cartegni, S.L. Chew, and A.R. Krainer Listening to silence and understanding nonsense: exonic mutations that affect splicing Nat. Rev. Genet. 3 2002 285 298
5. C. Collesi, M.M. Santoro, G. Gaudino, and P.M. Comoglio A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype Mol. Cell. Biol. 16 1996 5518 5526
6. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
7. N.A. Faustino, and T.A. Cooper Pre-mRNA splicing and human disease Genes Dev. 17 2003 419 437
8. D.C. Fischer, K. Noack, I.B. Runnebaum, D.O. Watermann, D.G. Kieback, S. Stamm, and E. Stickeler Expression of splicing factors in human ovarian cancer Oncol. Rep. 11 2004 1085 1090
9. X.D. Fu The superfamily of arginine/serine-rich splicing factors RNA 1 1995 663 680
10. G. Gaudino, A. Follenzi, L. Naldini, C. Collesi, M. Santoro, K.A. Gallo, P.J. Godowski, and P.M. Comoglio RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP EMBO J. 13 1994 3524 3532
11. H. Ge, and J.L. Manley A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro Cell 62 1990 25 34
12. C. Ghigna, M. Moroni, C. Porta, S. Riva, and G. Biamonti Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas Cancer Res. 58 1998 5818 5824
13. A. Hanamura, J.F. Caceres, A. Mayeda, B.R. Franza Jr., and A.R. Krainer Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors RNA 4 1998 430 444
14. Y. Huang, and J.A. Steitz SRprises along a messenger's journey Mol. Cell 17 2005 613 615
15. H. Itoh, Y. Hattori, H. Sakamoto, H. Ishii, T. Kishi, H. Sasaki, T. Yoshida, M. Koono, T. Sugimura, and M. Terada Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity Cancer Res. 54 1994 3237 3241
16. J.M. Johnson, J. Castle, P. Garrett-Engele, Z. Kan, P.M. Loerch, C.D. Armour, R. Santos, E.E. Schadt, R. Stoughton, and D.D. Shoemaker Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays Science 302 2003 2141 2144
17. P. Jordan, R. Brazao, M.G. Boavida, C. Gespach, and E. Chastre Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors Oncogene 18 1999 6835 6839
18. H. Jumaa, and P.J. Nielsen The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation EMBO J. 16 1997 5077 5085
19. J.L. Kan, and M.R. Green Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor Genes Dev. 13 1999 462 471
20. T. Kashima, and J.L. Manley A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy Nat. Genet. 34 2003 460 463
21. A.R. Krainer, G.C. Conway, and D. Kozak The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites Cell 62 1990 35 42
22. H.X. Liu, M. Zhang, and A.R. Krainer Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins Genes Dev. 12 1998 1998 2012
23. A.J. Lopez Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation Annu. Rev. Genet. 32 1998 279 305
24. J.L. Manley, and R. Tacke SR proteins and splicing control Genes Dev. 10 1996 1569 1579
25. R. Rossi, A. Villa, C. Negri, I. Scovassi, G. Ciarrocchi, G. Biamonti, and A. Montecucco The replication factory targeting sequence/PCNA-binding site is required in G(1) to control the phosphorylation status of DNA ligase I EMBO J. 18 1999 5745 5754
26. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning: A Laboratory Manual 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor NY
27. H. Shen, J.L. Kan, and M.R. Green Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly Mol. Cell 13 2004 367 376
28. C.W. Smith, and J. Valcarcel Alternative pre-mRNA splicing: the logic of combinatorial control Trends Biochem. Sci. 25 2000 381 388
29. E. Stickeler, F. Kittrell, D. Medina, and S.M. Berget Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis Oncogene 18 1999 3574 3582
30. R. Tacke, and J.L. Manley The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities EMBO J. 14 1995 3540 3551
31. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat. Rev. Cancer 2 2002 442 454
32. L. Trusolino, and P.M. Comoglio Scatter-factor and semaphorin receptors: cell signalling for invasive growth Nat. Rev. Cancer 2 2002 289 300
33. J. Valcarcel, and M.R. Green The SR protein family: pleiotropic functions in pre-mRNA splicing Trends Biochem. Sci. 21 1996 296 301
34. D. Wang, Q. Shen, Y.Q. Chen, and M.H. Wang Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase Oncogene 23 2004 1668 1680
35. H.Y. Wang, X. Xu, J.H. Ding, J.R. Bermingham Jr., and X.D. Fu SC35 plays a role in T cell development and alternative splicing of CD45 Mol. Cell 7 2001 331 342
36. X. Xu, D. Yang, J.H. Ding, W. Wang, P.H. Chu, N.D. Dalton, H.Y. Wang, J.R. Bermingham Jr., Z. Ye, and F. Liu ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle Cell 120 2005 59 72
37. L.K. Zerbe, I. Pino, R. Pio, P.F. Cosper, L.D. Dwyer-Nield, A.M. Meyer, J.D. Port, L.M. Montuenga, and A.M. Malkinson Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing Mol. Carcinog. 41 2004 187 196
38. Y.Q. Zhou, C. He, Y.Q. Chen, D. Wang, and M.H. Wang Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential Oncogene 22 2003 186 197